Searched for
PHARMACEUTICAL
US exempts India and 19 nations from 100% tariff on certain speciality drugs: ReportThe United States has announced it will exempt certain speciality drugs and ingredients imported from India and 19 other countries from tar...- CDSCO steps up scrutiny of pharma drugs containing narcotic substancesThe Central Drugs Standard Control Organisation is addressing regulatory gaps related to the illegal diversion of pharmaceutical drugs. Fol...
- India electronics firms get Rs 19,091 crore PLI incentives, investments cross Rs 20,580 croreElectronics manufacturing companies have received substantial incentives under the production-linked incentive scheme and attracted signifi...
- Steamhouse India wins Rs 311 crore EPC mandate for 300 TPH steam project in Himachal PradeshSteamhouse India Ltd has secured a Rs 311 crore EPC mandate for a 300 TPH common steam and co-generation power plant at the Bulk Drug Park ...
- Nearly 7 billion litres without a market: Ethanol glut in India fuels search for new buyersIndia’s ethanol industry is deluged with severe oversupply, with nearly 7 billion litres of capacity without a clear market. Installed capa...
- Rs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in IndiaNovartis and Eli Lilly have opposed a Kerala High Court petition seeking government intervention to make two breast cancer drugs cheaper, d...
- Deon Energy files draft papers with Sebi to raise funds via IPODeon Energy, an Ahmedabad-based solar EPC firm, is set to launch an IPO to gather capital. This offering will feature a fresh equity share ...
- Govt disburses Rs 36,754 cr under PLI schemes as on June 30The government has disbursed Rs 36,754 crore to beneficiary companies under the Production Linked Incentive schemes. These schemes have led...
- India records highest-ever FDI of $94.53 billion in FY26, inflows since 2014 reach $843 billion: Piyush GoyalIndia achieved its highest-ever annual Foreign Direct Investment of USD 94.53 billion in FY 2025-26. Cumulative FDI inflows from FY 2014-15...
- Sanofi Healthcare buys 15.2% stake in Sanofi India for Rs 1,068 croreSanofi Healthcare India acquired a significant 15.2 percent stake in Sanofi India through an open market transaction. The company purchased...
- Jagsonpal Pharma to acquire Group Pharma’s wellness portfolioJagsonpal Pharmaceuticals has signed a business transfer agreement to acquire the wellness portfolio of Group Pharmaceuticals. The acquisit...
- Pharma sector revenue to grow 11-13 pc in FY27 on strong exports, domestic demand: CrisilIndia's pharmaceutical sector is projected to grow at 11-13 percent this fiscal year due to export increases. The domestic market is also e...
- Zydus Lifesciences expects decent growth for five years as innovation matures: Sharvil PatelZydus Lifesciences is transitioning from a traditional pharmaceutical company to a more patient-driven organization. The company plans to f...
- Gautam Adani reclaims richest Indian spot from Mukesh Ambani as India's billionaire count hits record: HurunGautam Adani has overtaken Mukesh Ambani to reclaim the top spot on the M3M Hurun India Rich List 2026, with wealth of Rs 9.23 lakh crore. ...
- Gautam Adani reclaims top spot as India’s richest, edges out Mukesh Ambani: Hurun Rich ListGautam Adani has overtaken Mukesh Ambani to reclaim the top spot on the M3M Hurun India Rich List 2026, with wealth of Rs 9.23 lakh crore. ...
- 'Inflated medicine prices are daylight robbery': SC pulls up pharma companies over huge MRP-PTR gapSupreme Court on Tuesday questioned the wide gap between the price to retailer and MRP of some cancer medicines, calling inflated pricing a...
- European pharma chiefs warn region risks losing ground to America, ChinaDrugmakers for months have been warning they could curtail investments and delay the release of new medications in Europe, widening a dispa...
- MF Tracker: HDFC Pharma & Healthcare Fund tops equity MFs at 25% in 1 year. Should investors chase the rally?HDFC Pharma and Healthcare Fund recorded an impressive 25% return in the last year, surpassing its category average across various time fra...
- ENTOD Pharmaceuticals secures patent for its insulin eye dropCurrently at the pre-clinical stage of development, the patented insulin eye drops are being investigated as a potential novel therapeutic ...
- Government to ease BA-BE study norms for domestic generic drug approvals, cut import licence timelinesPharmaceutical companies will soon find it easier to conduct drug studies. Applicants can start eligible trials after intimating the drug r...
Load More
